Cargando…

Propargyl-Linked Antifolates Are Potent Inhibitors of Drug-Sensitive and Drug-Resistant Mycobacterium tuberculosis

Mycobacterium tuberculosis continues to cause widespread, life-threatening disease. In the last decade, this threat has grown dramatically as multi- and extensively-drug resistant (MDR and XDR) bacteria have spread globally and the number of agents that effectively treat these infections is signific...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hajian, Behnoush, Scocchera, Eric, Keshipeddy, Santosh, G-Dayanandan, Narendran, Shoen, Carolyn, Krucinska, Jolanta, Reeve, Stephanie, Cynamon, Michael, Anderson, Amy C., Wright, Dennis L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006990/ https://www.ncbi.nlm.nih.gov/pubmed/27580226 http://dx.doi.org/10.1371/journal.pone.0161740

Ejemplares similares

Propargyl-Linked Antifolates are Dual Inhibitors of Candida albicans and Candida glabrata
por: G-Dayanandan, Narendran, et al.
Publicado: (2014)

Structure-Guided In Vitro to In Vivo Pharmacokinetic Optimization of Propargyl-Linked Antifolates
por: Lombardo, M.N., et al.
Publicado: (2019)

Toward New Therapeutics for Skin and Soft Tissue Infections: Propargyl-Linked Antifolates Are Potent Inhibitors of MRSA and Streptococcus pyogenes
por: Viswanathan, Kishore, et al.
Publicado: (2012)

Chiral evasion and stereospecific antifolate resistance in Staphylococcus aureus
por: Wang, Siyu, et al.
Publicado: (2022)

Characterization of trimethoprim resistant E. coli dihydrofolate reductase mutants by mass spectrometry and inhibition by propargyl-linked antifolates
por: Cammarata, Michael, et al.
Publicado: (2017)

Therapy for Mycobacterium kansasii Infection: Beyond 2018
por: DeStefano, Michelle S., et al.
Publicado: (2018)

2148. In vitro Potency of a Leucyl-tRNA Synthetase Inhibitor, MRX-6038, Against Mycobacterium tuberculosis, Mycobacterium avium, and Mycobacterium abscessus
por: Shoen, Carolyn M, et al.
Publicado: (2023)

Dual-Target Mycobacterium tuberculosis Inhibition: Insights into the Molecular Mechanism of Antifolate Drugs
por: Ramharack, Pritika, et al.
Publicado: (2023)

1704. Epetraborole, a Novel Bacterial Leucyl-tRNA Synthetase Inhibitor, Demonstrates Potent Efficacy and Improves Efficacy of Standard of Care Regimen Against Mycobacterium avium complex in a Chronic Mouse Lung Infection Model
por: De, Kavita, et al.
Publicado: (2022)

Culture-Free Enumeration of Mycobacterium tuberculosis in Mouse Tissues Using the Molecular Bacterial Load Assay for Preclinical Drug Development
por: Evangelopoulos, Dimitrios, et al.
Publicado: (2022)

Developing Tadpole Xenopus laevis as a Comparative Animal Model to Study Mycobacterium abscessus Pathogenicity
por: Lopez, Arianna, et al.
Publicado: (2021)

The Role of Folate Transport in Antifolate Drug Action in Trypanosoma brucei
por: Dewar, Simon, et al.
Publicado: (2016)

Differential chemosensitivity to antifolate drugs between RAS and BRAF melanoma cells
por: Arozarena, Imanol, et al.
Publicado: (2014)

Escalating Plasmodium falciparum antifolate drug resistance mutations in Macha, rural Zambia
por: Mkulama, Mtawa AP, et al.
Publicado: (2008)

Effect of folate derivatives on the activity of antifolate drugs used against malaria and cancer
por: Nduati, Eunice, et al.
Publicado: (2008)

Prevalence and patterns of antifolate and chloroquine drug resistance markers in Plasmodium vivax across Pakistan
por: Khattak, Aamer A, et al.
Publicado: (2013)

MYC predetermines the sensitivity of gastrointestinal cancer to antifolate drugs through regulating TYMS transcription
por: Liu, Tingting, et al.
Publicado: (2019)

Activity of antifolates against Pneumocystis carinii dihydrofolate reductase and identification of a potent new agent
Publicado: (1987)

First-in-class multifunctional TYMS nonclassical antifolate inhibitor with potent in vivo activity that prolongs survival
por: Guijarro, Maria V., et al.
Publicado: (2023)

The prevalence and antifolate drug resistance profiles of Plasmodium falciparum in study participants randomized to discontinue or continue cotrimoxazole prophylaxis
por: Juma, Dennis W., et al.
Publicado: (2019)

Synthesis and Biological Evaluation of 2,4-Diaminopyrimidine-Based Antifolate Drugs against Bacillus anthracis
por: Nammalwar, Baskar, et al.
Publicado: (2014)

New Classes of Alanine Racemase Inhibitors Identified by High-Throughput Screening Show Antimicrobial Activity against Mycobacterium tuberculosis
por: Anthony, Karen G., et al.
Publicado: (2011)

Molecular surveillance of putative drug resistance markers of antifolate and artemisinin among imported Plasmodium falciparum in Qatar
por: Bansal, Devendra, et al.
Publicado: (2019)

Methionyl-tRNA formyltransferase utilizes 10-formyldihydrofolate as an alternative substrate and impacts antifolate drug action
por: Sah, Shivjee, et al.
Publicado: (2023)

Cu-catalyzed, Mn-mediated propargylation and allenylation of aldehydes with propargyl bromides
por: Zhang, Rongli, et al.
Publicado: (2022)

Prevalence of chloroquine and antifolate drug resistance alleles in Plasmodium falciparum clinical isolates from three areas in Ghana
por: Abugri, James, et al.
Publicado: (2018)

Platinum-Triggered Bond-Cleavage of Pentynoyl Amide and N-Propargyl Handles for Drug-Activation
por: Oliveira, Bruno L., et al.
Publicado: (2020)

Bengamides display potent activity against drug-resistant Mycobacterium tuberculosis
por: Quan, Diana H., et al.
Publicado: (2019)

Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs
por: Corominas-Faja, Bruna, et al.
Publicado: (2012)

Biological Activity and Intracellular Metabolism of ZD1694 in Human Leukemia Cell Lines with Different Resistance Mechanisms to Antifolate Drugs
por: Takemura, Yuzuru, et al.
Publicado: (1996)

Unlocking the Molecular Secrets of Antifolate Drug Resistance: A Multi-Omics Investigation of the NCI-60 Cell Line Panel
por: Rushing, Blake R.
Publicado: (2023)

Photoredox cobalt-catalyzed regio-, diastereo- and enantioselective propargylation of aldehydes via propargyl radicals
por: Wang, Lei, et al.
Publicado: (2023)

Polymorphism of Antifolate Drug Resistance in Plasmodium vivax From Local Residents and Migrant Workers Returned From the China-Myanmar Border
por: Zeng, Weilin, et al.
Publicado: (2021)

A Study of Solvent Effects in the Solvolysis of Propargyl Chloroformate
por: D'Souza, Malcolm J., et al.
Publicado: (2011)

The Impact of Short-Term, Intensive Antifolate Treatment (with Pyrimethamine and Sulfadoxine) and Antibiotics Followed by Long-Term, Secondary Antifolate Prophylaxis on the Rate of Toxoplasmic Retinochoroiditis Recurrence
por: Borkowski, Piotr K., et al.
Publicado: (2016)

Pharmacokinetic studies with the antifolate C2-desamino-C2-methyl-N10-propargyl-2'-trifluoromethyl-5,8-dideazafolic acid (CB3988) in mice and rats using in vivo 19F-NMR spectroscopy.
por: Newell, D. R., et al.
Publicado: (1990)

Prevalence of antifolate resistance mutations in Plasmodium falciparum isolates in Afghanistan
por: Awab, Ghulam R, et al.
Publicado: (2013)

Antifolate Agents Against Wild and Mutant Strains of Plasmodium falciparum
por: Shaikh, M. S., et al.
Publicado: (2014)

Factors Influencing the Antifolate Activity of Synthetic Tea-Derived Catechins
por: Sáez-Ayala, Magalí, et al.
Publicado: (2013)

Folate transporter dynamics and therapy with classic and tumor-targeted antifolates
por: O’Connor, Carrie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1cuik5bbfv9nlkmnf4i82pfl6g